MASH新药上半年大卖3.5亿美元,全年预计8亿美元

医药魔方Info
Aug 06

8月5日,Madrigal Pharmaceuticals发布2025年第二季度业绩,Rezdiffra(Resmetirom)大卖2.128亿美元,环比增长55%,上半年总计销售额为3.501亿美元。基于此,Madrigal Pharmaceuticals预计该产品的全年销售额可以达到8亿+美元。Resmetirom是罗氏发现的一款能够选择性激活甲状腺激素受体β(THR-β)的口服小分子药物。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10